Medscape Medical NewsAll articles

CT 5300

Philips Healthcare (Suzhou) Co., Ltd. • Radiology • 05/03/2024

510(k)IEC 62304 Class B
FDA Summary PDF

Device Purpose

The CT 5300 is a multi-slice computed tomography X-ray system designed for comprehensive diagnostic imaging, including head, whole body, cardiac, vascular applications, and low-dose lung cancer screening across all patient ages. Its methodology relies on computer reconstruction of X-ray transmission data acquired from a rotating gantry, enhanced by AI-driven software for image noise reduction ("Precise Image") and automated patient positioning ("Precise Position") to improve image quality and workflow efficiency.

Summary

The Philips CT 5300 is a computed tomography X-ray system designed to produce cross-sectional images of the head and body for diagnostic purposes across all patient ages. Its applications include general head and body imaging, as well as specialized cardiac and vascular examinations, and importantly, it is indicated for low-dose CT lung cancer screening for early nodule detection. The system operates by acquiring X-ray transmission data at various angles and planes using a continuously rotating X-ray tube and detector array housed within a gantry. This data is then processed by a computer to reconstruct detailed images. The system features a 72 cm bore, a 50 cm scan field of view, and can be configured for mobile use with a "CT on Trailer Kit," allowing for deployment in diverse healthcare environments. Key components of the CT 5300 include the gantry (with X-ray tube, high-voltage generator, A-plane for slice adjustment, and Data Management System), a patient table, and an operator console. The system's science involves advanced image reconstruction algorithms and incorporates several software features for data acquisition, display, manipulation, and post-processing. Notably, it utilizes AI-enhanced tools such as "Precise Image," a deep learning neural network for image noise reduction, which enables half-dose imaging with diagnostic quality comparable to full-dose iDose4 reconstructions, and "Precise Position," a camera-based AI algorithm for automated patient positioning. Non-clinical testing, including phantom studies and radiologist evaluations, confirmed the performance of these features, demonstrating the system's capability to deliver high-quality diagnostic images for a wide range of clinical scenarios, including newly supported cardiac and high-resolution head imaging, while optimizing radiation dose.

AI Regulatory Concerns

Powered byJev by TypeSafe AI

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

Keywords

Computed Tomography (CT)X-Ray SystemDiagnostic ImagingWhole Body ScanCardiac ImagingVascular ImagingLung Cancer ScreeningImage ReconstructionPrecise Image (AI)Precise Position (AI)

Device Metadata

Submission Number
K232491
Company
Philips Healthcare (Suzhou) Co., Ltd.
Panel
Radiology
Product Code
N/A
Data Type
Images
Clinical Function
Assessment
AI Function
Generation|Analysis
AI Subclass
image enhancement|quantification/feature localization

Relevant Clinical Questions

  • Q1. Considering the modifications to "Precise Image" for cardiac applications, what specific image quality metrics (e.g., temporal resolution, contrast-to-noise ratio for coronary arteries) were assessed, and how do they compare to established benchmarks or prior iterative reconstruction techniques?; How does the "Precise Position" AI algorithm account for anatomical variability across diverse patient populations (e.g., obese, pediatric, elderly) when automatically setting vertical centering and scan ranges for the newly supported cardiac, spine, and runoff exams?; The "CT on Trailer Kit" enables mobile deployment. What specific performance verifications were conducted to ensure image quality and system stability are maintained under the conditions of transportation and varied setup environments compared to a fixed hospital installation?; For the low-dose CT lung cancer screening indication, what specific dose levels are achieved with the CT 5300, and how does the "Precise Image" reconstruction algorithm contribute to maintaining diagnostic image quality at these reduced doses, particularly for small nodule detection?; The documentation states "Precise Image" was compared using half-dose reconstructions with full-dose iDose4 reconstructions. What was the quantitative reduction in radiation dose (e.g., CTDIvol, DLP) achieved with "Precise Image" while maintaining comparable diagnostic quality for the various new applications, such as cardiac and high-resolution head imaging?

Risk Classification

ESL Analysis
FDA Device ClassII

FDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Post-§524B but no clear network capability detected

Learn how Parasoft automates IEC 62304 compliance testing →

Cybersecurity Evidence

Powered by SBOMator™

Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.

Cyber Score20/100
SBOM Evidence⚠ Not in summary - likely in full submission per §524B
Cyber Risk Assessment⚠ Not in summary - likely in full submission per §524B
Postmarket Plan⚠ Not in summary - likely in full submission per §524B
§524B ApplicableYes

Supply Chain BOM Evidence

Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.

SBOMSoftware Bill of Materials
- Not detected
ML-BOMMachine Learning Bill of Materials(deep learning, neural network, algorithm)
✓ Detected
SaaSBOMSoftware-as-a-Service Bill of Materials(network, platform)
✓ Detected
HBOMHardware Bill of Materials(camera)
✓ Detected
CBOMCryptography Bill of Materials
- Not detected
VDR/VEXVulnerability Disclosure Report / Vulnerability Exploitability eXchange
- Not detected
OBOMOperations Bill of Materials(deployment, environment)
✓ Detected

Analysis:

• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.

• Evidence of ML-BOM, SaaSBOM, HBOM, OBOM detected in AI-generated device summary.

• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.

• Cybersecurity risk assessment not referenced in AI-generated device summary. FDA cybersecurity guidance (2023) expects this for cyber devices.

• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.

• Not detected in AI-generated device summary: SBOM, CBOM, VDR/VEX. These may be present in the full FDA submission.

Preparing a similar submission?

ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.

Assess Your Readiness →Or contact ESL directly
CT 5300 - Philips Healthcare (Suzhou) Co., Ltd. | ESL FDA AI Device Intelligence